United Therapeutics traded at $241.90 this Wednesday July 6th, increasing $4.75 or 2.00 percent since the previous trading session. Looking back, over the last four weeks, United Therapeutics gained 5.81 percent. Over the last 12 months, its price rose by 29.37 percent. Looking ahead, we forecast United Therapeutics to be priced at 231.55 by the end of this quarter and at 213.23 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Amarin 1.56 -0.03 -1.89% -63.29%
Ardelyx 0.62 0.01 1.98% -92.12%
Baxter International 65.11 -0.28 -0.43% -20.45%
Bayer 56.91 0.72 1.28% 12.47%
BioCryst Pharmaceuticals 11.23 0.09 0.81% -29.33%
Biogen 215.98 3.40 1.60% -39.22%
BioMarin Pharmaceutical 86.41 0.05 0.06% 4.06%
Emergent BioSolutions 32.84 -0.42 -1.26% -46.63%
Esperion Therapeutics 6.69 -0.30 -4.29% -65.25%
Gilead Sciences 62.73 0.39 0.63% -8.24%
GlaxoSmithKline 1,793.40 3.20 0.18% 25.76%
Halozyme Therapeutics 46.75 0.42 0.91% 2.48%
Intercept Pharmaceuticals 15.29 0.14 0.92% -19.44%
Insmed 22.06 0.78 3.67% -20.82%
Ionis Pharmaceuticals 36.81 -1.04 -2.75% -5.52%
Intra Cellular Therapies 56.17 -0.92 -1.61% 37.00%
J&J 178.30 0.16 0.09% 5.25%
Lexicon Pharmaceuticals 2.63 -0.12 -4.36% -32.39%
Moderna Inc 159.56 4.02 2.58% -28.09%
Omeros 3.58 0.49 15.86% -75.56%
Pfizer 52.75 1.11 2.15% 34.05%
PTC Therapeutics 42.91 -0.87 -1.99% -2.57%
Regeneron Pharmaceuticals 594.90 -1.66 -0.28% 1.54%
Seattle Genetics 175.13 -1.64 -0.93% 16.96%
Sangamo BioSciences 4.59 -0.08 -1.71% -57.81%
Sarepta Therapeutics 75.97 0.23 0.30% 5.53%
Teva Pharmaceutical Industries Ltd 2,656.00 0 0% -14.29%
United Therapeutics 241.90 4.75 2.00% 29.37%
Vertex Pharmaceuticals 291.16 2.18 0.75% 46.32%

Indexes Price Day Year
USND 11362 39.61 0.35% -22.52%
US400 2279 -13.85 -0.60% -15.05%

United Therapeutics
United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The Company market and sell four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution, which includes the Tyvaso Inhalation System; Orenitram (treprostinil) Extended-Release Tablets; and Adcirca (tadalafil) Tablets. In the United States, the Company also markets and sells an oncology product, Unituxin (dinutuximab) Injection, which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion.